KRRO VS ZYXI Stock Comparison
Performance
KRRO100/100
100/100
KRRO returned 192.66% in the last 12 months. Based on SPY's performance of 13.09%, its performance is above average giving it a score of 100 of 100.
ZYXI100/100
100/100
ZYXI returned 26.01% in the last 12 months. Based on the other stocks in its sector with an average return of -7.39%, its performance is above average giving it a grade of 100 of 100.
Earnings
KRRO100/100
100/100
KRRO has missed earnings 0 times in the last 20 quarters.
ZYXI24/100
24/100
ZYXI has missed earnings 4 times in the last 20 quarters.
Volatility
KRRO100/100
100/100
KRRO has had a higher than average amount of volatility over the last 12 months giving it a score of 100 of 100.
ZYXI56/100
56/100
ZYXI has had a higher than average amount of volatility over the last 12 months giving it a grade of 55 of 100.
Forecast
KRRO
"Forecast" not found for KRRO
ZYXI75/100
75/100
1 analysts offer 12-month price forecasts for ZYXI. Together, they have an average target of 18, the most optimistic forecast put ZYXI at 18 within 12-months and the most pessimistic has ZYXI at 18.
Sentiment
KRRO
"Sentiment" not found for KRRO
ZYXI66/100
66/100
ZYXI had a bullish sentiment score of 66.34% across Twitter and StockTwits over the last 12 months. It had an average of 10.80 posts, 99.52 comments, and 227.58 likes per day.
Technicals
KRRO
"Technicals" not found for KRRO
ZYXI10/100
10/100
ZYXI receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.
Profit
KRRO
"Profit" not found for KRRO
ZYXI58/100
58/100
Out of the last 20 quarters, ZYXI has had 14 profitable quarters and has increased their profits year over year on 7 of them.
Dividend
KRRO
"Dividend" not found for KRRO
ZYXI15/100
15/100
ZYXI's most recent dividend was $0.06 per share, based on a share price of $9.40. It was a payout ratio of 96.13% compared to their total earnings.
All score calculations are broken down here to help you make more informed investing decisions
Korro Bio, Inc. Common Stock Summary
Nasdaq / KRRO
Healthcare
Biotechnology
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
ZYNEX INC Summary
Nasdaq / ZYXI
Healthcare
Medical - Distribution
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Compare Similar Companies
Compare KRRO to other companies in the same or a similar industry.